The Heme Oxygenase System and Type-1 Diabetes

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|9|1328-1337

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.9, 2014-03, pp. : 1328-1337

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Heme Oxygenase-Derived Carbon Monoxide Restores Vascular Function in Type 1 Diabetes

By  

Drug Metabolism Letters, Vol. 2, Iss. 4, 2008-12 ,pp. : 290-300

Bentham Science Publishers

Access to resources Recommend Favorite

A Critical and Comprehensive Insight on Heme Oxygenase and Related Products Including Carbon Monoxide, Bilirubin, Biliverdin and Ferritin in Type-1 and Type-2 Diabetes

By  

Current Pharmaceutical Design, Vol. 20, Iss. 9, 2014-03 ,pp. : 1370-1391

Bentham Science Publishers

Access to resources Recommend Favorite

Inducers of Heme Oxygenase-1

By  

Current Pharmaceutical Design, Vol. 14, Iss. 5, 2008-02 ,pp. : 473-486

Bentham Science Publishers

Access to resources Recommend Favorite

Heme Oxygenase-1 in Lung Disease

By  

Current Drug Targets, Vol. 11, Iss. 12, 2010-01 ,pp. : 1532-1540

Bentham Science Publishers

Access to resources Recommend Favorite

New Biotechnological Methods to Reduce Oxidative Stress in the Cardiovascular System: Focusing on the Bach1/Heme Oxygenase-1 Pathway

By  

Current Pharmaceutical Biotechnology, Vol. 7, Iss. 2, 2006-04 ,pp. : 87-93

Bentham Science Publishers

Access to resources Recommend Favorite